P W Serruys

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi request reprint Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy
    Joanna J Wykrzykowska
    The Department of Interventional Cardiology Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 5:310-7. 2009
  2. doi request reprint Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
    Patrick W Serruys
    Thoraxcenter, Ba583, Erasmus MC, Rotterdam, Netherlands
    Circulation 118:1172-82. 2008
  3. pmc Bioresorbable scaffolds in the treatment of coronary artery disease
    Yaojun Zhang
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Division of Cardiovascular Diseases, Nanjing First Hospital, Nanjing Medical University, Nanjing, People s Republic of China
    Med Devices (Auckl) 6:37-48. 2013
  4. pmc Update on stents: recent studies on the TAXUS stent system in small vessels
    Shuzou Tanimoto
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Vasc Health Risk Manag 3:481-90. 2007
  5. pmc Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease
    Carlos M Campos
    Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam 3015 GD, The Netherlands
    Int J Mol Sci 14:24492-500. 2013
  6. pmc Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
    Salvatore Brugaletta
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, s Gravendijkwal 230, 3015, Rotterdam, CE, The Netherlands
    Int J Cardiovasc Imaging 28:1307-14. 2012
  7. pmc Bioresorbable scaffolds: current evidence and ongoing clinical trials
    Christos V Bourantas
    Thoraxcenter, Erasmus Medical Center, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Curr Cardiol Rep 14:626-34. 2012
  8. doi request reprint Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus
    Patrick W Serruys
    Thoraxcenter, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 6:777-89. 2013
  9. doi request reprint Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 128:141-51. 2013
  10. doi request reprint Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Heart 99:626-33. 2013

Detail Information

Publications180 found, 100 shown here

  1. ncbi request reprint Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy
    Joanna J Wykrzykowska
    The Department of Interventional Cardiology Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    EuroIntervention 5:310-7. 2009
    ..In this substudy of the LEADERS trial, we compared the performance of biolimus biodegradable polymer (BES) and sirolimus permanent polymer stents (SES) in long lesions...
  2. doi request reprint Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque
    Patrick W Serruys
    Thoraxcenter, Ba583, Erasmus MC, Rotterdam, Netherlands
    Circulation 118:1172-82. 2008
    ....
  3. pmc Bioresorbable scaffolds in the treatment of coronary artery disease
    Yaojun Zhang
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Division of Cardiovascular Diseases, Nanjing First Hospital, Nanjing Medical University, Nanjing, People s Republic of China
    Med Devices (Auckl) 6:37-48. 2013
    ..The aim of this review is to present the new developments in BRS technology, describe the mechanisms involved in the resorption process, and discuss the potential future prospects of this innovative therapy...
  4. pmc Update on stents: recent studies on the TAXUS stent system in small vessels
    Shuzou Tanimoto
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Vasc Health Risk Manag 3:481-90. 2007
    ....
  5. pmc Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease
    Carlos M Campos
    Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam 3015 GD, The Netherlands
    Int J Mol Sci 14:24492-500. 2013
    ..The aim of this review is to present the new developments in Magnesium BRS technology, to describe its clinical application and to discuss the future prospects of this innovative therapy. ..
  6. pmc Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
    Salvatore Brugaletta
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, s Gravendijkwal 230, 3015, Rotterdam, CE, The Netherlands
    Int J Cardiovasc Imaging 28:1307-14. 2012
    ..Larger studies are required to investigate the clinical impact of these findings...
  7. pmc Bioresorbable scaffolds: current evidence and ongoing clinical trials
    Christos V Bourantas
    Thoraxcenter, Erasmus Medical Center, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Curr Cardiol Rep 14:626-34. 2012
    ....
  8. doi request reprint Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus
    Patrick W Serruys
    Thoraxcenter, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 6:777-89. 2013
    ..This study sought to report the final 5 years follow-up of the landmark LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) trial...
  9. doi request reprint Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 128:141-51. 2013
    ..The residual Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Score is an objective measure of the degree and complexity of residual stenosis after percutaneous coronary intervention (PCI)...
  10. doi request reprint Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Heart 99:626-33. 2013
    ....
  11. doi request reprint Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSO
    Roberto Diletti
    Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Heart 99:98-105. 2013
    ..Therefore, we investigated the impact of vessel size on long-term outcomes, after Absorb BVS implantation...
  12. doi request reprint Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting
    Pascal Vranckx
    Department of Cardiac Intensive Care and Interventional Cardiology, Hartcentrum Hasselt, Hasselt, Belgium
    Heart 98:1424-30. 2012
    ..To assess the differential implications of cardiac biomarker type on peri-procedural myocardial infarction (PMI) reporting...
  13. doi request reprint A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years
    Patrick W Serruys
    Department of Interventional Cardiology, Erasmus University, Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 5:606-17. 2012
    ....
  14. pmc Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT
    Juan Luis Gutiérrez-Chico
    Erasmus Medical Centre, Thoraxcenter, Ba583a, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 28:467-78. 2012
    ..Volumetric calculations using solid state IVUS are therefore not reliable. There is poor agreement for MLA estimation between all the imaging modalities studied, including IVUS-OCT, hence their values are not interchangeable...
  15. pmc Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot resu
    Bill D Gogas
    Thoraxcenter, Erasmus University Medical Centre, s Gravendijkwaal 230, 3015 Rotterdam, The Netherlands
    Int J Cardiovasc Imaging 28:499-511. 2012
    ..However, histology systematically gives larger values for all the measured structures compared to OCT, at 2 years post implantation...
  16. pmc Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study
    Joanna J Wykrzykowska
    Interventional Cardiology, Thoraxcenter, Erasmus MC, University Medical Center, s Gravendijkwal 230, 3015CE, Rotterdam, The Netherlands
    J Thromb Thrombolysis 28:410-7. 2009
    ..The latter hypothesis may be less likely given decrease in hsCRP levels. Randomized studies are urgently needed to establish potential link of clopidogrel discontinuation and vascular outcomes...
  17. pmc Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Curr Cardiol Rep 13:415-23. 2011
    ..The emerging concepts of the patient-empowered risk/benefit tradeoff between PCI and CABG to help personalize the choice of revascularization modality are also explored...
  18. pmc Simulation of stent deployment in a realistic human coronary artery
    Frank J H Gijsen
    Department of Biomedical Engineering, Thoraxcentre EE2322, Erasmus Medical Center Rotterdam, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    Biomed Eng Online 7:23. 2008
    ..The knowledge of these parameters after stent deployment in a patient derived 3D reconstruction of a diseased coronary artery might give insights in the understanding of the process of restenosis...
  19. ncbi request reprint Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 44:1363-7. 2004
    ..We sought to demonstrate the safety and performance of the actinomycin D-coated Multilink-Tetra stent(Guidant Corp., Santa Clara, California) in the treatment of patients with single de novo native coronary lesions...
  20. ncbi request reprint Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial
    Patrick W Serruys
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circulation 109:627-33. 2004
    ..We used serial intravascular ultrasound (IVUS) to prospectively analyze vessel responses in adjacent reference segments after implantation of polymer-controlled paclitaxel-eluting stents...
  21. ncbi request reprint Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents
    Patrick W Serruys
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 115:1433-9; discussion 1439. 2007
  22. pmc Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)
    P W Serruys
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Heart 90:995-8. 2004
  23. ncbi request reprint Fourth annual American College of Cardiology international lecture: a journey in the interventional field
    Patrick W Serruys
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 47:1754-68. 2006
  24. ncbi request reprint Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo i
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 44:528-37. 2004
    ..We sought to assess the efficacy of vascular brachytherapy (VBT) combined with stenting for the primary prevention of restenosis...
  25. ncbi request reprint A European multi-center trial investigating the anti-restenotic effect of intravascular sonotherapy after stenting of de novo lesions (EUROSPAH: EUROpean Sonotherapy Prevention of Arterial Hyperplasia)
    P W Serruys
    Thoraxcentre, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 6:53-60. 2004
    ..Intravascular sonotherapy (IST) reduces neointimal hyperplasia post-stenting in animal studies. Euro-SPAH is a multi-center, double blind, randomized trial investigating the efficacy of IST to reduce in-stent late loss...
  26. ncbi request reprint Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial
    Patrick W Serruys
    Interventional Cardiology Department, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:575-81. 2005
    ..The long-term (five-year) comparative results of treatment of multivessel coronary artery disease with stenting or coronary artery bypass grafting (CABG) is at present unknown...
  27. ncbi request reprint The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 46:253-60. 2005
    ..The aim of this study was to evaluate the effect of variable dose and release kinetics of paclitaxel on neointimal hyperplasia...
  28. ncbi request reprint Clinical development of bivalirudin (Angiox): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes
    P W Serruys
    Department of Cardiology, Thoraxcentre, Erasmus MC, Cardialysis Clinical Research Management and Core Laboratories, Rotterdam, The Netherlands
    Int J Clin Pract 60:344-50. 2006
    ..This paper will discuss the clinical development of the direct thrombin inhibitor bivalirudin as the core anticoagulant in the contemporary PCI setting and the implications for its use in ACS...
  29. ncbi request reprint Biodegradable stents
    S Ramcharitar
    Department of Interventional, Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Minerva Cardioangiol 56:205-13. 2008
    ..Their behaviour will not only redefine current percutaneous coronary intervention but may also have a wider role in the cardiovascular system as whole...
  30. doi request reprint Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention
    Vasim Farooq
    Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands
    Heart 97:1902-13. 2011
    ....
  31. doi request reprint Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes
    Patrick W Serruys
    Thorax Center, Erasmus Medical Center, Gravendijkwal 230, Rotterdam, The Netherlands
    J Am Coll Cardiol 58:1578-88. 2011
    ..The aim of this study was to demonstrate that the prevention of early scaffold area shrinkage of the ABSORB BVS (Rev.1.1, Abbott Vascular, Santa Clara, California) was sustained and not simply delayed by a few months...
  32. doi request reprint Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes
    Patrick W Serruys
    Thoraxcenter, Ba 583, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    Circulation 122:2301-12. 2010
    ..Nevertheless, late luminal loss was less than that observed with bare metal stents. To maintain the mechanical integrity of the device up to 6 months, the scaffold design and manufacturing process of its polymer were modified...
  33. doi request reprint Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Yosinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 6:447-53. 2010
    ..Nevertheless, the long-term safety and efficacy of this novel therapy remain to be documented...
  34. ncbi request reprint A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
    Patrick W Serruys
    Erasmus Medisch Centrum, Rotterdam, The Netherlands
    EuroIntervention 6:195-205. 2010
    ..Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents; however it requires a lower dose, and less polymer, and is therefore conceivably safer...
  35. doi request reprint Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease
    Cihan Simsek
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Dr Molewaterplein 40, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 76:41-9. 2010
    ..There are limited data on the long-term safety and efficacy profile of coronary stent implantation in patients with stable coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI)...
  36. doi request reprint 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions
    Patrick W Serruys
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 55:1093-101. 2010
    ....
  37. ncbi request reprint Assessment of the SYNTAX score in the Syntax study
    Patrick W Serruys
    Department of Interventional Cardiology, Erasmus Medical Center, Thoraxcenter Rotterdam, The Netherlands
    EuroIntervention 5:50-6. 2009
    ....
  38. doi request reprint Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (
    N Kukreja
    Thoraxcenter, Ba 583, s Gravendijkwal 230, Rotterdam 3015 CE, The Netherlands
    Heart 95:1061-6. 2009
    ..We therefore analysed the clinical outcome of patients in ARTS-I and ARTS-II with proximal LAD involvement...
  39. ncbi request reprint Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease
    Patrick W Serruys
    Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
    N Engl J Med 360:961-72. 2009
    ..Our trial compared PCI and CABG for treating patients with previously untreated three-vessel or left main coronary artery disease (or both)...
  40. ncbi request reprint Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement
    Patrick W Serruys
    Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 5:214-22. 2003
    ..The aim of the study was to determine whether a single intravenous infusion of 25 mg/kg CDP860, a humanized di-Fab' fragment against PDGF-beta receptor, leads to a reduction of in-stent restenosis...
  41. ncbi request reprint Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
    Patrick W Serruys
    Department of Cardiology, Erasmus Medical Center, Molewaterplein 40, Ba 583, 3015 GD Rotterdam, The Netherlands
    N Engl J Med 363:136-46. 2010
    ..However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration...
  42. doi request reprint Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomo
    Yoshinobu Onuma
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Circulation 122:2288-300. 2010
    ..We therefore report OCT findings with corresponding histology in the porcine coronary artery model immediately after and at 28 days and 2, 3, and 4 years after BVS implantation...
  43. ncbi request reprint Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
    I P Kay
    Thoraxcenter, University Hospital Rotterdam, Dijkzigt, The Netherlands
    Circulation 103:14-7. 2001
    ..Clinical outcome 1 year after the implantation of stents with an initial activity of 6 to 12 microCi is not favorable when compared with conventional stenting...
  44. ncbi request reprint "Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff
    W J van der Giessen
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Circulation 104:2236-41. 2001
    ....
  45. ncbi request reprint Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-Radiation In Europe
    G Sianos
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, The Netherlands
    J Am Coll Cardiol 38:415-20. 2001
    ..6%, respectively, p = 0.8). CONCLUSIONS: Geographical miss is strongly associated with restenosis at the edges of the EIRS. This effect is more prominent when caused by stenting. Geographical miss does not increase restenosis in the EIRS...
  46. ncbi request reprint Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up
    B J Rensing
    Department of Interventional Cardiology, Thoraxcenter, Rotterdam, The Netherlands
    Eur Heart J 22:2125-30. 2001
    ..3 mm(3)and 1.8%, respectively. No edge effect was observed in the segments proximal and distal to the stents. CONCLUSION: Implantation of a sirolimus-eluting stent seems to effectively prevent intimal hyperplasia...
  47. ncbi request reprint Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty
    M Albertal
    Thoraxcenter, Amsterdam, The Netherlands
    Am Heart J 142:81-6. 2001
    ..03 to 1.07) were associated with a lack of improvement at follow-up. CONCLUSIONS: The detection of SVA was associated with failure of improvement in functional activity at follow-up after coronary intervention...
  48. ncbi request reprint Value of coronary stenotic flow velocity acceleration in prediction of angiographic restenosis following balloon angioplasty
    M Albertal
    Interventional Cardiology, Hartcentrum, Thoraxcenter, Academisch Ziekenhuis Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur Heart J 23:1849-53. 2002
    ..Quantitative angiographic assessment after balloon angioplasty is a poor predictor of immediate and long-term outcome. However, the measurement of blood flow velocity during angioplasty has been proved clinically useful...
  49. ncbi request reprint Methodological considerations and approach to cross-technique comparisons using in vivo coronary plaque characterization based on intravascular ultrasound radiofrequency data analysis: insights from the Integrated Biomarker and Imaging Study (IBIS)
    G A Rodriguez-Granillo
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Int J Cardiovasc Intervent 7:52-8. 2005
    ..IVUS-VH was not included at the start of the IBIS protocol. The purpose of this paper is to describe the methodology we used to obtain and analyse IVUS-VH images and the approach to cross-correlations with the other techniques...
  50. ncbi request reprint Comparison of brachytherapy strategies based on dose-volume histograms derived from quantitative intravascular ultrasound
    S G Carlier
    Department of Interventional Cardiology, Thoraxcenter, Erasmus University Rotterdam, The Netherlands
    Cardiovasc Radiat Med 1:115-24. 1999
    ..This paper discusses the potential merits of dose-volume histograms (DVH) based on three-dimensional (3-D) reconstruction of electrocardiogram (ECG)-gated intravascular ultrasound (IVUS) to compare brachytherapy treatment strategies...
  51. ncbi request reprint The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation
    I P Kay
    Thoraxcenter, Rotterdam, The Netherlands
    Eur Heart J 22:1311-7. 2001
    ..0%) and 11.4 mm3 (25.6%), respectively (P=0.017). At the stent edges there was no significant change in lumen volume. CONCLUSIONS: Cold-end stenting results in increased neointimal hyperplasia in in-stent non-radioactive segments...
  52. ncbi request reprint Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
    P W Serruys
    University Hospital Rotterdam Dijkzigt, Thorax Center, Rotterdam, The Netherlands
    Lancet 352:673-81. 1998
    ....
  53. ncbi request reprint True 3-dimensional reconstruction of coronary arteries in patients by fusion of angiography and IVUS (ANGUS) and its quantitative validation
    C J Slager
    Thoraxcenter, University Hospital Rotterdam Dijkzigt, Erasmus University Rotterdam, Utrecht, Netherlands
    Circulation 102:511-6. 2000
    ..99). Geometric measurements in silhouette images of the 3D reconstructions showed high correlation (0.84 to 0.97) with corresponding measurements in the actual biplane angiographic images...
  54. ncbi request reprint Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery disease
    A J Wardeh
    Thoraxcenter Rotterdam, University Hospital Rotterdam, Dijkzigt, The Netherlands
    Eur Heart J 22:669-75. 2001
    ..30+/-0.53 (stent area). CONCLUSION: These results indicate that the use of radioactive stents is safe and feasible, however, the high incidence of edge restenosis makes this technique currently clinically non-applicable...
  55. pmc Long term outcome after intracoronary beta radiation therapy
    G Sianos
    Department of Interventional Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    Heart 91:942-7. 2005
    ..To determine the long term outcome after intracoronary beta radiation therapy (IRT)...
  56. ncbi request reprint Stenting with a true bifurcated stent: acute and mid-term follow-up results
    S G Carlier
    Interventional Department, Rotterdam Heart Center, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 47:361-96. 1999
    ..Cathet. Cardiovasc. Intervent. 47:361-369, 1999...
  57. ncbi request reprint Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up
    R T van Domburg
    The Department of Cardiac Catheterization and Interventional Cardiology, Thoraxcenter, Erasmus University and University Hospital Dijkzigt Rotterdam, The Netherlands
    Eur Heart J 22:934-41. 2001
    ....
  58. doi request reprint Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
    Yoshinobu Onuma
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:584-94. 2010
    ....
  59. ncbi request reprint Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)
    M A Costa
    University Hospital Dijkzigt, Thoraxcentrum, Rotterdam, The Netherlands
    Circulation 104:2689-93. 2001
    ....
  60. ncbi request reprint Quantitative measurements of in-stent restenosis: A comparison between quantitative coronary ultrasound and quantitative coronary angiography
    N Bruining
    Thoraxcenter, Department of Cardiology, Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 48:133-42. 1999
    ..This is of particular relevance to quantitative studies addressing absolute changes in vascular or luminal diameters. Cathet. Cardiovasc. Intervent. 48:133-142, 1999...
  61. ncbi request reprint Guidance of intracoronary radiation therapy based on dose-volume histograms derived from quantitative intravascular ultrasound
    S G Carlier
    Department of Intervention Cardiology, Thoraxcentre, Erasmus University Rotterdam, The Netherlands
    IEEE Trans Med Imaging 17:772-8. 1998
    ..5) conducted in our institution are presented, supporting the use of DVH based on quantitative IVUS measurements for optimal dose prescription in vascular interventional radiation therapy...
  62. pmc Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry
    F Saia
    Department of Invasive Cardiology, Thoraxcentre, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Heart 90:1183-8. 2004
    ....
  63. ncbi request reprint Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory
    Marco Valgimigli
    Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
    J Cardiovasc Med (Hagerstown) 8:221-9. 2007
    ..Thus, a combination of several modalities will be important in the future to ensure a high sensitivity and specificity in detecting vulnerable plaques...
  64. doi request reprint Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing
    Wim J van der Giessen
    Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:284-90. 2009
    ....
  65. doi request reprint Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry
    Zhu jun Shen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 74:979-86. 2009
    ..The objective of this report was to evaluate the outcomes of these patients at 5-years clinical follow-up...
  66. ncbi request reprint Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease
    M Degertekin
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Minerva Cardioangiol 50:405-18. 2002
    ..As compare with standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis and associated clinical events...
  67. ncbi request reprint Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing
    N Mercado
    Thoraxcentre, University Hospital Dijkzigt, Rotterdam, The Netherlands
    Eur Heart J 24:541-51. 2003
    ..e. dilatation of angiographically non-significant lesions) compared to moderate and severe stenoses...
  68. doi request reprint Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach
    N Gonzalo
    Thoraxcenter, Erasmus MC, 3015 CE Rotterdam, The Netherlands
    Heart 95:1913-9. 2009
    ....
  69. ncbi request reprint The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L Study
    D P Foley
    Interventional Cardiology, Thoraxcentre Bd 414, Academic Hospital Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands
    Eur Heart J 22:1585-93. 2001
    ..Long coronary lesions provide a challenging substrate for emerging antirestenosis therapies, such as stent coatings and brachytherapy...
  70. ncbi request reprint The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe
    J J Piek
    Department of Cardiology, Academical Medical Center, Amsterdam, The Netherlands
    Eur Heart J 22:1725-32. 2001
    ..Coronary flow reserve alterations in patients without restenosis were related to changes in hyperaemic blood flow velocity, suggesting that this phenomenon relates to epicardial remodelling...
  71. ncbi request reprint True reconstruction of vessel geometry from combined X-ray angiographic and intracoronary ultrasound data
    C J Slager
    Thoraxcenter, University Hospital Rotterdam Dijkzigt, The Netherlands
    Semin Interv Cardiol 2:43-7. 1997
    ..Application of such a method will be helpful to understand immediate and long-term vessel remodelling induced by all types of catheter interventions and in the study of progression or regression of atherosclerotic wall disease...
  72. ncbi request reprint Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry
    Hector M Garcia-Garcia
    Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands
    Catheter Cardiovasc Interv 70:635-9. 2007
    ..There are currently no long-term results of the efficacy of SES in this subset of lesions. We assessed the 3-year clinical outcomes of 147 patients with CTO treated with either SES or bare metal stents (BMS)...
  73. ncbi request reprint Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation
    Andrew T L Ong
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 45:947-53. 2005
    ....
  74. ncbi request reprint Initial observation regarding changes in vessel dimensions after balloon angioplasty and stenting followed by catheter-based beta-radiation. Is stenting necessary in the setting of catheter-based radiotherapy?
    K Kozuma
    Department of Cardiology, Thoraxcentre, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur Heart J 23:641-9. 2002
    ..We sought to compare the effect of intracoronary beta-radiation on the vessel dimensions in de novo lesions using three-dimensional intravascular ultrasound quantification after balloon angioplasty and stenting...
  75. ncbi request reprint Characterization of plaque components and vulnerability with intravascular ultrasound elastography
    C L de Korte
    Erasmus University, Rotterdam, The Netherlands
    Phys Med Biol 45:1465-75. 2000
    ..Intravascular elastography provides information that is frequently unavailable or inconclusive from the IVUS image and which may therefore assist in the diagnosis and treatment of atherosclerotic disease...
  76. ncbi request reprint Acute and 6-month clinical and angiographic outcome after implantation of the ACS Duet stent for single-vessel coronary artery disease: final results of the European and US ACS Multi-link Duet Registry
    D P Foley
    Department of Interventional Cardiology Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 54:25-33. 2001
    ..With late outcomes at least comparable to the best published results, this stent platform provides safe and effective percutaneous treatment of obstructive coronary artery disease. Cathet Cardiovasc Intervent 2001;54:25-33...
  77. ncbi request reprint [Sirolimus-releasing coronary stent: lessons from the Rotterdam experience]
    P A Lemos
    Thoraxcenter, Université Erasme, Rotterdam, Pays Bas
    Ann Cardiol Angeiol (Paris) 53:32s-35s. 2004
  78. ncbi request reprint Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era
    N Mercado
    Thoraxcenter, University Hospital Dijkzigt, Rotterdam, The Netherlands
    J Am Coll Cardiol 38:645-52. 2001
    ..Still important, but more so in the stent population, is a large post-MLD (optimal result). Finally, a larger pre-RD became a favorable predictor with the advent of stenting...
  79. pmc Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patients
    R T van Domburg
    Department of Cardiac Catheterization and Interventional Cardiology, Erasmus University and University Hospital Rotterdam, Thoraxcenter, Bd 308, Dr Molewaterplein 40, 3015 GD, Rotterdam, Netherlands
    Heart 82:II27-34. 1999
    ..To describe the long term clinical outcome (up to 11 years) after coronary stenting...
  80. ncbi request reprint Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries)
    Joost Daemen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 99:1027-32. 2007
    ..A high frequency of stent thrombosis was observed in the 2 drug-eluting stent groups...
  81. ncbi request reprint Fate of side branches after coronary arterial sirolimus-eluting stent implantation
    Kengo Tanabe
    Thoraxcenter, Rotterdam, The Netherlands
    Am J Cardiol 90:937-41. 2002
    ..Thus, the fate of side branches after SES implantation is favorable and at least as good as after UMS implantation...
  82. doi request reprint Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy
    Joanna J Wykrzykowska
    Department of Interventional Cardiology Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:861-70. 2009
    ..We assessed the impact of vessel size on outcomes of stenting with biolimus-eluting degradable polymer stent (BES) and sirolimus-eluting permanent polymer stent (SES) within a randomized multicenter trial (LEADERS)...
  83. ncbi request reprint Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up
    Muzaffer Degertekin
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    Circulation 106:1610-3. 2002
    ..The objective of our study was to evaluate the efficiency of sirolimus-eluting stent implantation for up to 2 years of follow-up...
  84. pmc One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents
    S H Hofma
    Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands
    Heart 91:1176-80. 2005
    ..To compare clinical outcome of paclitaxel eluting stents (PES) versus sirolimus eluting stents (SES) for the treatment of acute ST elevation myocardial infarction...
  85. ncbi request reprint Advancing intravascular ultrasonic palpation toward clinical applications
    M M Doyley
    Thoraxcentre, Erasmus University, Rotterdam 3000 DR The Netherlands
    Ultrasound Med Biol 27:1471-80. 2001
    ..Although the clinical results are clearly preliminary, it was concluded that the prototype system performed sufficiently well to warrant further and more in-depth clinical investigation...
  86. ncbi request reprint Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC
    P W Serruys
    Department of Interventional Cardiology, Thoraxcenter, Academisch Ziekenhuis, Rotterdam, The Netherlands
    J Am Coll Cardiol 34:1067-74. 1999
    ..We aimed to identify periprocedural quantitative coronary angiographic (QCA) variables that have predictive value on long-term angiographic results and to construct multivariate models using these variables for postprocedural prognosis...
  87. ncbi request reprint Stent development and local drug delivery
    E Regar
    Department of Cardiology, Thoraxcentre, Erasmus Medical Centre Rotterdam, The Netherlands
    Br Med Bull 59:227-48. 2001
    ..The clinical benefit of these approaches still has to be proven...
  88. ncbi request reprint The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound
    P W Serruys
    Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Eur Heart J 22:1938-47. 2001
    ..29). CONCLUSION: Oral trapidil 600 mg daily for 6 months did not reduce in-stent hyperplasia or improve clinical outcome after successful Wallstent implantation and is not indicated for this purpose...
  89. ncbi request reprint Flow estimation using an intravascular imaging catheter
    A F van der Steen
    Thorax Centre, Erasmus University, Rotterdam, The Netherlands
    Ultrasonics 38:363-8. 2000
    ..Although the principle is the same, the method needs some adaptation through the inherent different beamforming of the transducer. In this paper various aspects of the development of IVUS flow are reviewed...
  90. ncbi request reprint Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial
    P J de Feyter
    Catheterization Laboratory, Thoraxcenter, Erasmus University, Rotterdam, The Netherlands
    Circulation 81:III99-106. 1990
    ..Thus, xamoterol can be a useful addition for the treatment of left ventricular dysfunction because of long-term ischemic heart disease...
  91. ncbi request reprint The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n = 6129)
    Joost Daemen
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 4:464-74. 2009
    ..There is still limited data about the long-term safety and efficacy of DES in high-risk subgroups...
  92. ncbi request reprint Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry
    Joost Daemen
    The Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 98:895-901. 2006
    ..The beneficial effects, reported after 1 and 2 years in reducing major adverse cardiac events, persisted with no evidence of a clinical late restenotic "catch-up" phenomenon...
  93. ncbi request reprint Shear stress, vascular remodeling and neointimal formation
    Jolanda J Wentzel
    Department of Cardiology, Thoraxcentre EE2322, Erasmus Medical Centre Rotterdam, Erasmus University Rotterdam, P O Box 1738, 3000 DR Rotterdam, Netherlands
    J Biomech 36:681-8. 2003
    ..Attempts to locally increase shear stress by a newly developed flow divider indicate that shear stress reduce in-stent neointimal formation by 50%...
  94. ncbi request reprint Images in Cardiovascular Medicine. True three-dimensional reconstructed images showing lumen enlargement after sirolimus-eluting stent implantation
    Kengo Tanabe
    Division of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands
    Circulation 106:e179-80. 2002
  95. ncbi request reprint Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention
    Hector M Garcia-Garcia
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    EuroIntervention 4:607-16. 2009
    ..To define better the role of CTCA in the treatment of patients with CTOs, we performed CTCA in a consecutive cohort of eligible patients who were scheduled for percutaneous recanalisation of a CTO...
  96. doi request reprint Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation
    Chris van der Lee
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Cardiol 101:1315-20. 2008
    ..Late PTSMA failure could not be predicted by baseline characteristics but could partially be explained by a learning-curve effect. This finding implies that PTSMA procedures should be restricted to experienced centers...
  97. ncbi request reprint Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?
    Stephane G Carlier
    Thoraxcentre, Erasmus Medical Center Rotterdam, Netherlands
    Circulation 107:2741-6. 2003
    ..We studied the causal relationship between WSS and NH formation in stents by locally increasing WSS with a flow divider (Anti-Restenotic Diffuser, Endoart SA) placed in the center of the stent...
  98. ncbi request reprint Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes
    Pedro A Lemos
    Erasmus Medical Center, Thoraxcenter, Rotterdam, The Netherlands
    Circulation 109:2500-2. 2004
    ..We evaluated the clinical and angiographic outcomes of patients presenting with restenosis after sirolimus-eluting stent (SES) implantation treated with repeated percutaneous intervention...
  99. doi request reprint 3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery)
    Chrysafios Girasis
    Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 3:41-8. 2010
    ..We explore the bifurcation angle (BA) parameters of the left main coronary artery (LM), the effect of percutaneous coronary intervention (PCI) on this angulation, and the impact of BA on clinical outcome...
  100. ncbi request reprint Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study
    Francesco Saia
    Erasmus MC, Thoraxcenter, Rotterdam, The Netherlands
    Catheter Cardiovasc Interv 61:455-60. 2004
    ..13 +/- 0.34 and restenosis rate was 7.7%. Although not routinely recommended in every patient, SES postdilatation with largely oversized balloons appears a safe and effective strategy for selected patients...
  101. doi request reprint The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents
    Neville Kukreja
    Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    JACC Cardiovasc Interv 2:534-41. 2009
    ..We aimed to evaluate the risk of definite stent thrombosis with bare-metal stents (BMS) and drug-eluting stents (DES) in patients treated for acute coronary syndromes...